Companies: 10,795·Total market cap: $144.5T
Emerald Health Therapeutics, Inc.

Emerald Health Therapeutics, Inc.

EMHTFOTCHealthcare
$0.04
+$0.01(+55.17%)
Market Cap$0
P/E Ratio
52W High$0.0681
52W Low$0.02

Emerald Health Therapeutics, Inc. (EMHTF) Shares Outstanding — Overview

Basic and diluted weighted average shares, YoY change, float context, and historical trend from SEC filings and FMP.

EMHTF · shares outstanding · updated Jun 9, 2026

Key metrics

Basic Shares Outstanding · Weighted average · fiscal year
193.2M +0.00% YoY Change
FY · as of Dec 31, 2021 · Reported in CAD
vs 193.2M in FY 2020
Diluted Shares Outstanding
193.2M
incl. options, RSUs, convertibles
Dilution Spread
+0.00%
Diluted vs Basic
YoY Change
+0.00%
year-over-year
Source: FMP /income-statement · /shares-float · SEC 10-K / 10-QUpdated: 2026-06-09

Shares Outstanding Growth Rate

3-Year CAGRincreasing
+10.9%
2018 → 2021
5-Year CAGRincreasing
+28.9%
2016 → 2021
10-Year CAGRincreasing
+57.9%
2011 → 2021

Negative CAGR typically indicates share buyback or retirement activity. Interpret alongside Splits and Financials tabs. Splits / Financials

Shares outstanding history

↓ Decrease — typically buyback / retirement
↑ Increase — issuance / equity compensation
Latest
* most recent reported · FMP /income-statement · weightedAverageShsOut

Annual shares outstanding by year

FY 2021Latest
Diluted Shares: 193.2M
193.2M
+0.00%
FY 2020
Diluted Shares: 193.2M
193.2M
+30.58%
FY 2019
Diluted Shares: 148.0M
148.0M
+4.61%
FY 2018
Diluted Shares: 141.4M
141.4M
+59.92%
FY 2017
Diluted Shares: 88.4M
88.4M
+62.99%
FMP /income-statement · weightedAverageShsOut · weightedAverageShsOutDilUnit: Billions (B)

Healthcare sector shares outstanding comparison

Shares Outstanding for similar companies or competitors in the Healthcare sector.

#SymbolCompanyShares (Basic)vs EMHTF
#1
Merck & Co., Inc.MRK
Merck & Co., Inc.
2.502B+>999%
#2
Johnson & JohnsonJNJ
Johnson & Johnson
2.429B+>999%
#3
AbbVie Inc.ABBV
AbbVie Inc.
1.780B+821.5%
#4
AstraZeneca PLCAZN
AstraZeneca PLC
1.550B+702.3%
#5
UnitedHealth Group IncorporatedUNH
UnitedHealth Group Incorporated
910.0M+371.0%
#6
Eli Lilly and CompanyLLY
Eli Lilly and Company
898.0M+364.8%
#7
Emerald Health Therapeutics, Inc.EMHTF
Emerald Health Therapeutics, Inc.YOU
193.2M

/company-screener · per-peer /income-statement · cache 86400s

Understanding Shares Outstanding

What Are Shares Outstanding? (Basic)

Emerald Health Therapeutics, Inc. (EMHTF) shares outstanding is the total number of issued shares held by shareholders — the basis for Basic EPS and market capitalization. As of December 31, 2021, Emerald Health Therapeutics, Inc. reports 193.2M basic shares outstanding (weighted average).

Basic vs. Diluted Shares Outstanding

Emerald Health Therapeutics, Inc.'s basic shares outstanding (193.2M) represents currently issued shares. Diluted shares outstanding (193.2M) also includes potential shares from stock options, RSUs, and convertibles. Dilution spread: +0.00%.

Shares Outstanding vs. Float (Free Float)

Emerald Health Therapeutics, Inc.'s float is — (— of total shares outstanding) — shares freely available for public trading, excluding insider-held and restricted shares.

Float data from /shares-float reflects the most recent SEC filing period-end. The weighted average shares (from /income-statement) may differ — this is a normal reporting window difference, not a data error.

FMP /income-statement · /shares-float · SEC EDGAR · CAD

About shares outstanding & methodology

Emerald Health Therapeutics, Inc. (EMHTF) shares outstanding history from 2009 to 2021. Shares outstanding can be defined as the total number of shares held by all shareholders — including institutional investors, retail investors, and company insiders — assuming conversion of all convertible debt, securities, warrants, and options. This metric excludes the company's treasury shares.

Emerald Health Therapeutics, Inc. shares outstanding for the fiscal year ending December 31, 2021 were 193.2M, a 0.00% increase year-over-year. Emerald Health Therapeutics, Inc. FY 2021 shares outstanding were 193.2M, a +0.00% increase from FY 2020.

Emerald Health Therapeutics, Inc. is a leading company operating in the Healthcare sector. The company's share count trajectory — with a 10-year CAGR of +57.9% — is a key signal for investors evaluating capital return policy, EPS accretion, and long-term shareholder value creation.

Figures tie to SEC 10-K/10-Q income statement disclosures and FMP /income-statement · /shares-float where noted.

Frequently asked questions

EMHTF shares outstanding · 4 questions

As of December 31, 2021, Emerald Health Therapeutics, Inc. (EMHTF) has approximately 193.2M basic shares outstanding and 193.2M diluted shares outstanding. This represents a +0.00% year-over-year increase from FY 2020 (193.2M). The increase may reflect equity compensation issuances or secondary offerings.

EMHTF shares outstandinghow many shares does EMHTF haveEMHTF basic shares 2021EMHTF diluted shares

Data: FMP /income-statement · /shares-float · SEC EDGAR · weighted average basis · Emerald Health Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: 2026-06-09